动脉树中C-X-C基序趋化因子受体4定向的PET信号与钙化斑块负担和心血管风险并不一致。

IF 13.3 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Theranostics Pub Date : 2025-01-01 DOI:10.7150/thno.102910
Aleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, Kerstin Michalski, Matthias Fröhlich, Niklas Dreher, Philipp E Hartrampf, Takahiro Higuchi, Andreas K Buck, Alexander Weich, Theresa Reiter, Rudolf A Werner
{"title":"动脉树中C-X-C基序趋化因子受体4定向的PET信号与钙化斑块负担和心血管风险并不一致。","authors":"Aleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, Kerstin Michalski, Matthias Fröhlich, Niklas Dreher, Philipp E Hartrampf, Takahiro Higuchi, Andreas K Buck, Alexander Weich, Theresa Reiter, Rudolf A Werner","doi":"10.7150/thno.102910","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To establish the extent, distribution and frequency of in-vivo vessel wall [<sup>68</sup>Ga]Ga-PentixaFor uptake and to determine its relationship with calcified atherosclerotic plaque burden (CAP) and cardiovascular risk factors (CVRF). <b>Methods:</b> 65 oncological patients undergoing [<sup>68</sup>Ga]Ga-PentixaFor PET/CT were assessed. Radiotracer uptake (target-to-background ratio [TBR]) and CAP burden (including number of CAP sites, calcification circumference and thickness) in seven major vessel segments per patient were determined. We then investigated associations of vessel wall uptake with CAP burden, cardiovascular risk (CVRF and European Society of Cardiology [ESC] SCORE2/SCORE2-OP risk chart) and image noise (determined by coefficient of variation [CoV] from unaffected liver parenchyma). <b>Results:</b> We identified 1292 sites of high focal [<sup>68</sup>Ga]Ga-PentixaFor uptake (PentixaFor+ sites) in the vessel wall in 65/65 (100%) patients, with concomitant calcification in 385/1292 (29.8%) sites. There were no significant associations between vessel wall uptake and CAP burden (number of PentixaFor+ sites: r ≤ 0.18, <i>P</i> ≥ 0.14; PentixaFor+ TBR: r ≤ 0.08, <i>P</i> ≥ 0.54). The number of PentixaFor+ sites showed a moderate correlation with cardiovascular risk (ESC SCORE2/SCORE2-OP, r = 0.30; number of CVRF, r = 0.26; <i>P</i> = 0.04, respectively), but failed to reach significance for PentixaFor+ TBR (r ≤ 0.18, <i>P</i> ≥ 0.22). In univariable regression analysis, body mass index (odds ratio [OR] 1.08, 95%-confidence interval [CI] 1.02-1.14) and CoV (OR, 1.07; CI, 1.05-1.10) were linked to TBR and the number of PentixaFor+ sites (<i>P</i> < 0.01, respectively), while injected activity was only associated with the latter imaging parameter (OR, 0.99; CI, 0.98-1.00; <i>P</i> = 0.04). In multivariable regression, injected activity (OR, 1.00; CI, 0.99-1.00) and CoV (OR, 1.06; CI, 1.06-1.07) remained significantly associated with the number of PentixaFor+ sites (<i>P</i> < 0.01, respectively). CoV, however, was the only parameter significantly linked to PentixaFor+ TBR on multivariable analysis (OR, 1.02; CI, 1.01-1.03; <i>P</i> < 0.01). <b>Conclusion:</b> On a visual and quantitative level, high focal [<sup>68</sup>Ga]Ga-PentixaFor uptake in the arterial tree was not consistently linked to vessel wall calcification or cardiovascular risk. Image noise, however, may account for a substantial portion of apparent vessel wall uptake.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"15 3","pages":"804-814"},"PeriodicalIF":13.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11700869/pdf/","citationCount":"0","resultStr":"{\"title\":\"C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular risk.\",\"authors\":\"Aleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, Kerstin Michalski, Matthias Fröhlich, Niklas Dreher, Philipp E Hartrampf, Takahiro Higuchi, Andreas K Buck, Alexander Weich, Theresa Reiter, Rudolf A Werner\",\"doi\":\"10.7150/thno.102910\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose:</b> To establish the extent, distribution and frequency of in-vivo vessel wall [<sup>68</sup>Ga]Ga-PentixaFor uptake and to determine its relationship with calcified atherosclerotic plaque burden (CAP) and cardiovascular risk factors (CVRF). <b>Methods:</b> 65 oncological patients undergoing [<sup>68</sup>Ga]Ga-PentixaFor PET/CT were assessed. Radiotracer uptake (target-to-background ratio [TBR]) and CAP burden (including number of CAP sites, calcification circumference and thickness) in seven major vessel segments per patient were determined. We then investigated associations of vessel wall uptake with CAP burden, cardiovascular risk (CVRF and European Society of Cardiology [ESC] SCORE2/SCORE2-OP risk chart) and image noise (determined by coefficient of variation [CoV] from unaffected liver parenchyma). <b>Results:</b> We identified 1292 sites of high focal [<sup>68</sup>Ga]Ga-PentixaFor uptake (PentixaFor+ sites) in the vessel wall in 65/65 (100%) patients, with concomitant calcification in 385/1292 (29.8%) sites. There were no significant associations between vessel wall uptake and CAP burden (number of PentixaFor+ sites: r ≤ 0.18, <i>P</i> ≥ 0.14; PentixaFor+ TBR: r ≤ 0.08, <i>P</i> ≥ 0.54). The number of PentixaFor+ sites showed a moderate correlation with cardiovascular risk (ESC SCORE2/SCORE2-OP, r = 0.30; number of CVRF, r = 0.26; <i>P</i> = 0.04, respectively), but failed to reach significance for PentixaFor+ TBR (r ≤ 0.18, <i>P</i> ≥ 0.22). In univariable regression analysis, body mass index (odds ratio [OR] 1.08, 95%-confidence interval [CI] 1.02-1.14) and CoV (OR, 1.07; CI, 1.05-1.10) were linked to TBR and the number of PentixaFor+ sites (<i>P</i> < 0.01, respectively), while injected activity was only associated with the latter imaging parameter (OR, 0.99; CI, 0.98-1.00; <i>P</i> = 0.04). In multivariable regression, injected activity (OR, 1.00; CI, 0.99-1.00) and CoV (OR, 1.06; CI, 1.06-1.07) remained significantly associated with the number of PentixaFor+ sites (<i>P</i> < 0.01, respectively). CoV, however, was the only parameter significantly linked to PentixaFor+ TBR on multivariable analysis (OR, 1.02; CI, 1.01-1.03; <i>P</i> < 0.01). <b>Conclusion:</b> On a visual and quantitative level, high focal [<sup>68</sup>Ga]Ga-PentixaFor uptake in the arterial tree was not consistently linked to vessel wall calcification or cardiovascular risk. Image noise, however, may account for a substantial portion of apparent vessel wall uptake.</p>\",\"PeriodicalId\":22932,\"journal\":{\"name\":\"Theranostics\",\"volume\":\"15 3\",\"pages\":\"804-814\"},\"PeriodicalIF\":13.3000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11700869/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Theranostics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7150/thno.102910\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.102910","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:建立体内血管壁[68Ga]Ga-PentixaFor摄取的范围、分布和频率,并确定其与钙化动脉粥样硬化斑块负荷(CAP)和心血管危险因素(CVRF)的关系。方法:对65例接受[68Ga]Ga-PentixaFor PET/CT治疗的肿瘤患者进行评估。测定每位患者7个主要血管节段的放射性示踪剂摄取(靶本比[TBR])和CAP负荷(包括CAP位置数、钙化周长和厚度)。然后,我们研究了血管壁摄取与CAP负担、心血管风险(CVRF和欧洲心脏病学会[ESC] SCORE2/SCORE2- op风险图)和图像噪声(由未受影响的肝实质的变异系数[CoV]决定)的关系。结果:我们在65/65(100%)患者的血管壁上发现了1292个高局灶[68Ga]Ga-PentixaFor摄取(PentixaFor+位点),其中385/1292(29.8%)位点伴有钙化。血管壁摄取与CAP负荷之间无显著相关性(PentixaFor+位点数:r≤0.18,P≥0.14;PentixaFor+ TBR: r≤0.08,P≥0.54)。PentixaFor+位点数量与心血管风险呈中等相关性(ESC SCORE2/SCORE2- op, r = 0.30;CVRF个数,r = 0.26;P = 0.04),但PentixaFor+ TBR未达到显著性(r≤0.18,P≥0.22)。在单变量回归分析中,体重指数(比值比[OR] 1.08, 95%可信区间[CI] 1.02-1.14)和冠状病毒(OR, 1.07;CI, 1.05-1.10)与TBR和PentixaFor+位点数量相关(P分别< 0.01),而注射活性仅与后一种成像参数相关(OR, 0.99;CI, 0.98 - -1.00;P = 0.04)。在多变量回归中,注射活性(OR, 1.00;CI, 0.99-1.00)和CoV (OR, 1.06;CI(1.06 ~ 1.07)与PentixaFor+位点数量呈显著相关(P < 0.01)。然而,在多变量分析中,CoV是唯一与PentixaFor+ TBR显著相关的参数(OR, 1.02;CI, 1.01 - -1.03;P < 0.01)。结论:在视觉和定量水平上,动脉树的高局灶[68Ga]Ga-PentixaFor摄取与血管壁钙化或心血管风险并不一致。然而,图像噪声可能占明显血管壁摄取的很大一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular risk.

Purpose: To establish the extent, distribution and frequency of in-vivo vessel wall [68Ga]Ga-PentixaFor uptake and to determine its relationship with calcified atherosclerotic plaque burden (CAP) and cardiovascular risk factors (CVRF). Methods: 65 oncological patients undergoing [68Ga]Ga-PentixaFor PET/CT were assessed. Radiotracer uptake (target-to-background ratio [TBR]) and CAP burden (including number of CAP sites, calcification circumference and thickness) in seven major vessel segments per patient were determined. We then investigated associations of vessel wall uptake with CAP burden, cardiovascular risk (CVRF and European Society of Cardiology [ESC] SCORE2/SCORE2-OP risk chart) and image noise (determined by coefficient of variation [CoV] from unaffected liver parenchyma). Results: We identified 1292 sites of high focal [68Ga]Ga-PentixaFor uptake (PentixaFor+ sites) in the vessel wall in 65/65 (100%) patients, with concomitant calcification in 385/1292 (29.8%) sites. There were no significant associations between vessel wall uptake and CAP burden (number of PentixaFor+ sites: r ≤ 0.18, P ≥ 0.14; PentixaFor+ TBR: r ≤ 0.08, P ≥ 0.54). The number of PentixaFor+ sites showed a moderate correlation with cardiovascular risk (ESC SCORE2/SCORE2-OP, r = 0.30; number of CVRF, r = 0.26; P = 0.04, respectively), but failed to reach significance for PentixaFor+ TBR (r ≤ 0.18, P ≥ 0.22). In univariable regression analysis, body mass index (odds ratio [OR] 1.08, 95%-confidence interval [CI] 1.02-1.14) and CoV (OR, 1.07; CI, 1.05-1.10) were linked to TBR and the number of PentixaFor+ sites (P < 0.01, respectively), while injected activity was only associated with the latter imaging parameter (OR, 0.99; CI, 0.98-1.00; P = 0.04). In multivariable regression, injected activity (OR, 1.00; CI, 0.99-1.00) and CoV (OR, 1.06; CI, 1.06-1.07) remained significantly associated with the number of PentixaFor+ sites (P < 0.01, respectively). CoV, however, was the only parameter significantly linked to PentixaFor+ TBR on multivariable analysis (OR, 1.02; CI, 1.01-1.03; P < 0.01). Conclusion: On a visual and quantitative level, high focal [68Ga]Ga-PentixaFor uptake in the arterial tree was not consistently linked to vessel wall calcification or cardiovascular risk. Image noise, however, may account for a substantial portion of apparent vessel wall uptake.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Theranostics
Theranostics MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
25.40
自引率
1.60%
发文量
433
审稿时长
1 months
期刊介绍: Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.
期刊最新文献
Mechanomedicine in digestive surgery: a theranostic framework integrating mechanical diagnostics and therapeutic modulation across the perioperative continuum. Quantitative assessment of extravasation of IL-15-secreting MSLN-CAR-NK-92 cells using tumor transparency imaging. Unraveling autophagy-metabolism crosstalk in cancer: Molecular insights and therapeutic strategies. A tumor-targeted heptamethine cyanine dye suppresses triple-negative breast cancer by induction of lethal autophagy. Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1